Centessa Pharmaceuticals (CNTA) Shares Issued (2021 - 2026)
Centessa Pharmaceuticals (CNTA) reported Shares Issued of $34.1 million for Q1 2026, up 458.54% year-over-year from $6.1 million in Q1 2025, and up 138.08% on a QoQ basis from $14.3 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) has 6 years of Shares Issued data on file, last reported at $34.1 million in Q1 2026.
- Quarterly Shares Issued rose 458.54% year-over-year to $34.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.4 million (up 199.27% YoY) and the FY2025 annual result came in at $21.4 million, up 90.27% from the prior year.
- Shares Issued grew to $34.1 million in Q1 2026 per CNTA's latest filing, from $14.3 million in the prior quarter.
- Across five years, Shares Issued topped out at $34.1 million in Q1 2026 and bottomed at -$2.6 million in Q2 2025.
- The 5-year median for Shares Issued is $568500.0 (2022), against an average of $4.2 million.
- The widest annual swing landed in 2024, when Shares Issued surged 6583.33%; it then slumped 429.3% in 2025.
- Tracing CNTA's Shares Issued over 5 years: stood at -$629000.0 in 2022, then soared by 118.76% to $118000.0 in 2023, then soared by 4427.12% to $5.3 million in 2024, then jumped by 168.29% to $14.3 million in 2025, then surged by 138.08% to $34.1 million in 2026.
- Per Business Quant, the three latest CNTA Shares Issued figures stand at $34.1 million (Q1 2026), $14.3 million (Q4 2025), and $3.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Centessa Pharmaceuticals | 6.12 Bn | 6.12 Bn | - | 34.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.12 Mn |
| Mar 31, 2026 | 34.12 Mn |
| Dec 31, 2025 | 14.33 Mn |
| Dec 31, 2025 | 14.33 Mn |
| Sep 30, 2025 | 3.56 Mn |
| Sep 30, 2025 | 3.56 Mn |
| Jun 30, 2025 | -2.64 Mn |
| Jun 30, 2025 | -2.64 Mn |
| Mar 31, 2025 | 6.11 Mn |
| Mar 31, 2025 | 6.11 Mn |
| Dec 31, 2024 | 5.34 Mn |
| Dec 31, 2024 | 5.34 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | 802,000.00 |
| Jun 30, 2024 | 802,000.00 |
| Mar 31, 2024 | 838,000.00 |
| Mar 31, 2024 | 838,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Dec 31, 2023 | 118,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Dec 31, 2022 | -629,000.00 |
| Dec 31, 2022 | -629,000.00 |
| Sep 30, 2022 | 224,000.00 |
| Sep 30, 2022 | 224,000.00 |
| Jun 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 70,000.00 |
| Mar 31, 2022 | 335,000.00 |
| Mar 31, 2022 | 335,000.00 |
| Dec 31, 2021 | 343.84 Mn |
| Dec 31, 2021 | 343.84 Mn |
| Mar 31, 2021 | 292,000.00 |
| Mar 31, 2021 | 292,000.00 |